Navigation Links
Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Television's "Taking Stock with Pimm Fox"
Date:3/1/2013

MIAMI LAKES, Fla., March 1, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals is pleased to announce that CEO Brian Tuffin and Daymond John , CEO of Shark Branding, LLC and Shark Branding Corp. are scheduled to be interviewed on Bloomberg Television's "Taking Stock with Pimm Fox" today, March 1st, 2013."Taking Stock", hosted by Bloomberg Television anchor Pimm Fox, offers insight into company news, long-term strategy, trading tactics, market techniques, stocks, bonds, commodities and currencies and is broadcast weekdays at 5:00 pm EST.

A replay of the interview will be archived and available within the Investor Relations section of the Fuse Science, Inc. corporate web site: http://ir.stockpr.com/fusescience/overview shortly after the broadcast.About Shark Branding Corp.Shark Branding's team of expert communicators, strategic analysts, and creative heavyweights excels in transforming businesses into iconic brands.  At the helm is business and branding expert Daymond John , CEO and Founder of FUBU, a $6 billion global fashion game-changer.  Daymond's entrepreneurialism and trend-moving influence are key to the company's cultivation of great brands.  Putting products in the hands of influencers and trendsetters is Shark Branding's core practice. Shark Branding clients benefit from a 360 degree approach to the growth of a healthy, successful brand with services ranging from brand strategy, design, and licensing; event development; celebrity affiliation and media; digital marketing; and the fundamentals of business leadership.  For more information, visit: www.sharkbranding.com

About Fuse Science, Inc.Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

For Fuse news as it happens, follow @Fuse_Science on Twitter and Like Us on Facebook HERE!For more information:To schedule an interview:Fuse Science, Inc.Gus DeQuesadaInvestor RelationsMichelsen AdvertisingDirect: (305) 503-3873, Ext. 2C-305-733-1410 / 786-488-7138Email: ir@fusescience.com

prnews@michelsenadvertising.comSafe Harbor StatementCertain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.


'/>"/>
SOURCE Fuse Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
2. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
3. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
4. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
5. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
6. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
7. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
8. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
9. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
11. Tonicology LLC Partners with Taiwan's CGB, Corp. to Offer Pure Extracts of Rare Herbal Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eutilex Co. Ltd. today announced that ... Series A financing. This financing round included participation from ... SNU Bio Angel. This new funding brings the total ... $27.7M) since its founding in 2015. ... and commercialization of its immuno-oncology programs, expand its R&D ...
(Date:12/7/2016)... ... December 07, 2016 , ... A new ... the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet ... population and timing of blood sampling may improve the value of a blood-based ...
(Date:12/7/2016)... CALGARY , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ... update that will be presented at the Company,s Annual and ... Meeting of Shareholders will take place on Thursday, December 15, ... Ross Glenn Hall (Room EC1040), 4825 Mount Royal Gate ... am (MST). A notice of meeting and management information circular, ...
(Date:12/7/2016)... 7, 2016  Vyriad Inc. announced today the appointment ... Board of Directors. "We are delighted to ... business and develop our oncolytic viruses as the next ... Stephen Russell , MD, PhD, CEO of Vyriad. "Al ... vision and passion for making a difference for cancer ...
Breaking Biology Technology:
(Date:12/5/2016)...  The Office of Justice Programs, National Institute ... Enhance or Replace Medico Legal Autopsies?" on NIJ.gov.  ... replacing forensic autopsies with postmortem X-ray computed tomography, ... response to recommendations made by The National Academy ... as a potential component of medicolegal death investigations. ...
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... 29, 2016   Neurotechnology , a ... recognition technologies, today released FingerCell 3.0, a ... solutions that run on low-power, low-memory microcontrollers. ... less than 128KB of memory, enabling it ... have limited on-board resources, such as: mobile ...
Breaking Biology News(10 mins):